Shanghai life sciences partner Katherine Wang was quoted in a June 27 International Devices & Diagnostics Monitor article on the China Food and Drug Administration (CFDA) requiring distributors of Class II and III medical devices to conduct self-inspections and report on their business activities.
Ms. Wang explains that subsidiary distributors acting as domestic agents for imported medical devices are key targets of the current CFDA enforcement campaign.
- Reprinted by Ropes & Gray with permission from Joya Patel, FDAnews.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.